BCL2 and prostate carcinoma: Studies of SINV-infected rat AT3-Bcl2 prostatic carcinoma cells showed that antibody treatment both increased RNA synthesis and inhibited virus budding leading to accumulation of nucleocapsids at the cell surface25.